Middle East & Africa Ruminant Vaccines Market Size & Outlook
Related Markets
MEA ruminant vaccines market highlights
- The MEA ruminant vaccines market generated a revenue of USD 264.0 million in 2024.
- The market is expected to grow at a CAGR of 9.2% from 2025 to 2030.
- In terms of segment, cattle was the largest revenue generating animal type in 2024.
- Sheep & Goats is the most lucrative animal type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 264.0 million |
| Market revenue in 2030 | USD 440.7 million |
| Growth rate | 9.2% (CAGR from 2025 to 2030) |
| Largest segment | Cattle |
| Fastest growing segment | Sheep & Goats |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cattle, Sheep & Goats |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.8% of the global ruminant vaccines market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,057.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ruminant Vaccines Market Scope
Ruminant Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim International GmbH | View profile | - | - | - |
| Merck & Co., Inc. | View profile | - | - | - |
| Vaxxinova | View profile | 51-100 | Nijmegen, Gelderland, The Netherlands, Europe | https://www.vaxxinova.com |
| Elanco | View profile | 10001+ | Greenfield, Indiana, United States, North America | https://www.elanco.com |
| CZ Vaccines | View profile | 101-250 | Pontevedra, Galicia, Spain, Europe | https://www.czvaccines.com |
| Bimeda | View profile | 1001-5000 | Dublin, Dublin, Ireland, Europe | https://www.bimeda.com/ |
| Indian Immunologicals | View profile | 1001-5000 | Hyderabad, Andhra Pradesh, India, Asia | https://indimmune.com |
| CEVA Inc | View profile | 424 | 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 | https://www.ceva-dsp.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
Middle East & Africa ruminant vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ruminant vaccines market will help companies and investors design strategic landscapes.
Cattle was the largest segment with a revenue share of 88.6% in 2024. Horizon Databook has segmented the Middle East & Africa ruminant vaccines market based on cattle, sheep & goats covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa ruminant vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa ruminant vaccines market databook
-
Our clientele includes a mix of ruminant vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa ruminant vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa ruminant vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA ruminant vaccines market size, by country, 2018-2030 (US$M)
Middle East & Africa Ruminant Vaccines Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
